Cellnovo and Home Diagnostics in patch pump pact
This article was originally published in Clinica
Home Diagnostics is to integrate its TRUE blood glucose monitoring device into Cellnovo’s insulin patch pumps to enable patients to monitor blood sugar levels using touchscreen controls. The agreement will see Home Diagnostics’ technology operate as a built-in blood glucose meter within the Cellnovo wireless handset, which is used to control the insulin patch pump. Glucose readings from the handset will be automatically stored and sent wirelessly to physicians, clinicians and family members. The Cellnovo pump is the smallest patch pump and the first to provide wireless, touchscreen operation, London, UK-based Cellnovo claims. In exchange for the product integration, Home Diagnostics (Fort Lauderdale, Florida) will provide Cellnovo with access to its distribution network in the US, which includes “45,000 points of distribution, leading insurance companies and major product suppliers”.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals